Mornington value up again 17.1 cents, page-15

The test samples gave us and the share price much encouragement. We all wait now for treatment in bulk to confirm the exceptional grades. If confirmed, the next question will be "How did previous management miss 10g/t in tails and publish assays for tails of 0.5g/t over four months?"

I can't see current management treating material which they weren't confident would run good grade. A poor result would be the undoing of all they have achieved.